nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse effects and safety of SGLT-2 inhibitors
|
Halimi, S. |
|
2014 |
|
6S1 |
p. S28-S34 7 p. |
artikel |
2 |
Basal insulin intensification in type 2 diabetes: a key role for GLP-1 receptor agonists
|
Charbonnel, Pr Bernard |
|
2015 |
|
6S1 |
p. 6S1-6S2 nvt p. |
artikel |
3 |
Beyond Glycosuria: Exploring the intrarenal effects of SGLT-2 inhibition in diabetes
|
Thomas, M.C. |
|
2014 |
|
6S1 |
p. S17-S22 6 p. |
artikel |
4 |
Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?
|
Bonnet, Fabrice |
|
2014 |
|
6S1 |
p. S1-S3 3 p. |
artikel |
5 |
Familial renal glycosuria and modifications of glucose renal excretion
|
Prié, D. |
|
2014 |
|
6S1 |
p. S12-S16 5 p. |
artikel |
6 |
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trials
|
Porcellati, F. |
|
2015 |
|
6S1 |
p. 6S16-6S20 nvt p. |
artikel |
7 |
Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence
|
Scheen, A.J. |
|
2014 |
|
6S1 |
p. S4-S11 8 p. |
artikel |
8 |
Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?
|
Darmon, P. |
|
2015 |
|
6S1 |
p. 6S21-6S27 nvt p. |
artikel |
9 |
Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control
|
Ahrén, B. |
|
2015 |
|
6S1 |
p. 6S3-6S8 nvt p. |
artikel |
10 |
Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the association
|
Cariou, B. |
|
2015 |
|
6S1 |
p. 6S28-6S35 nvt p. |
artikel |
11 |
Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications
|
Monnier, L. |
|
2015 |
|
6S1 |
p. 6S9-6S15 nvt p. |
artikel |
12 |
SGLT-2 inhibition in patients with kidney disease
|
Gilbert, R.E. |
|
2014 |
|
6S1 |
p. S23-S27 5 p. |
artikel |